HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 172 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $840,000 | +172.7% | 19,102 | +158.7% | 0.07% | +222.7% |
| Q1 2021 | $308,000 | -4.6% | 7,384 | -2.3% | 0.02% | -37.1% |
| Q4 2020 | $323,000 | -7.2% | 7,561 | -41.7% | 0.04% | -12.5% |
| Q2 2020 | $348,000 | +54.7% | 12,979 | -2.6% | 0.04% | +300.0% |
| Q2 2018 | $225,000 | -41.7% | 13,319 | -30.1% | 0.01% | -50.0% |
| Q4 2017 | $386,000 | -27.2% | 19,045 | -37.6% | 0.02% | -23.1% |
| Q3 2017 | $530,000 | – | 30,535 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |